Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.

ABSTRACT:

Importance

Combined-modality therapy with chemotherapy and radiation therapy plays a crucial role in the upfront treatment of patients with limited-stage small cell lung cancer (SCLC), but there may be barriers to utilization in the United States.

Objective

To estimate utilization rates and factors associated with chemotherapy and radiation therapy delivery for limited-stage SCLC using the National Cancer Database.

Design, setting, and participants

Analysis of initial management of all limited-stage SCLC cases from 2004 through 2013 in the National Cancer Database.

Main outcomes and measures

Utilization rates of chemotherapy and radiation therapy at time of initial treatment. Multivariable analysis identified independent clinical and socioeconomic factors assoc

SUBMITTER: Pezzi TA 

PROVIDER: S-EPMC5885163 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature